Wellesley Asset Management - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 25 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Wellesley Asset Management ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$63,000
-97.2%
65
-97.2%
0.00%
-97.4%
Q1 2022$2,245,000
-90.5%
2,304
-89.9%
0.15%
-94.6%
Q2 2021$23,719,0000.0%22,7510.0%2.84%0.0%
Q1 2021$23,719,000
+57.5%
22,751
+47.1%
2.84%
+226.5%
Q4 2020$15,056,000
+235.8%
15,462
+235.2%
0.87%
+75.3%
Q3 2020$4,483,000
+70.3%
4,613
+60.5%
0.50%
+57.3%
Q2 2020$2,633,000
+125.6%
2,874
+132.3%
0.32%
+130.7%
Q1 2020$1,167,0001,2370.14%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders